| Secondary |
| Drug Use For Unknown Indication |
37.8% |
| Product Used For Unknown Indication |
25.2% |
| Juvenile Arthritis |
9.0% |
| Acute Lymphocytic Leukaemia |
4.5% |
| Epilepsy |
3.6% |
| Ill-defined Disorder |
2.7% |
| Intentional Overdose |
2.7% |
| Antiretroviral Therapy |
1.8% |
| Diabetes Mellitus |
1.8% |
| Oral Candidiasis |
1.8% |
| Premedication |
1.8% |
| Anaesthesia |
0.9% |
| Arthralgia |
0.9% |
| Hypertension |
0.9% |
| Hypnotherapy |
0.9% |
| Prophylaxis |
0.9% |
| Pulmonary Oedema |
0.9% |
| Sedation |
0.9% |
| Vitamin Supplementation |
0.9% |
|
| Renal Failure Acute |
12.0% |
| Dementia |
8.0% |
| Rash |
8.0% |
| Rhabdomyolysis |
8.0% |
| Ventricular Tachycardia |
8.0% |
| Bezoar |
4.0% |
| Haemoptysis |
4.0% |
| Hepatitis |
4.0% |
| Nausea |
4.0% |
| Neck Pain |
4.0% |
| Pneumonia Klebsiella |
4.0% |
| Sinus Arrhythmia |
4.0% |
| Tardive Dyskinesia |
4.0% |
| Toxicity To Various Agents |
4.0% |
| Ulcer |
4.0% |
| Unresponsive To Stimuli |
4.0% |
| Vomiting |
4.0% |
| Weight Decreased |
4.0% |
| White Blood Cell Count Increased |
4.0% |
|
| Concomitant |
| Anticoagulant Therapy |
17.4% |
| Drug Use For Unknown Indication |
12.8% |
| Product Used For Unknown Indication |
12.6% |
| Multiple Myeloma |
7.4% |
| Prophylaxis Against Gastrointestinal Ulcer |
7.0% |
| Atrial Fibrillation |
6.6% |
| Prophylaxis |
4.8% |
| Cerebrovascular Accident Prophylaxis |
3.7% |
| Antifungal Prophylaxis |
3.3% |
| Hypertension |
2.9% |
| Inflammatory Bowel Disease |
2.9% |
| Acute Myeloid Leukaemia |
2.5% |
| Crohn's Disease |
2.5% |
| Pain |
2.5% |
| Rheumatoid Arthritis |
2.5% |
| Gastrooesophageal Reflux Disease |
2.1% |
| Hiv Infection |
1.9% |
| Cardiac Failure |
1.7% |
| Depression |
1.7% |
| Asthma |
1.4% |
|
| Gastrointestinal Haemorrhage |
13.3% |
| Large Intestinal Haemorrhage |
10.7% |
| Gastric Haemorrhage |
6.7% |
| Ventricular Septal Defect |
6.7% |
| Vomiting |
6.7% |
| Colitis Ulcerative |
5.3% |
| Death |
5.3% |
| Small Intestinal Haemorrhage |
5.3% |
| Weight Decreased |
5.3% |
| Anaemia |
4.0% |
| Cerebral Infarction |
4.0% |
| Progressive Multifocal Leukoencephalopathy |
4.0% |
| Upper Gastrointestinal Haemorrhage |
4.0% |
| Bronchopulmonary Aspergillosis |
2.7% |
| Cerebrovascular Accident |
2.7% |
| Diarrhoea |
2.7% |
| Drug Ineffective |
2.7% |
| Dysphagia |
2.7% |
| Electrocardiogram Qt Prolonged |
2.7% |
| Fractured Sacrum |
2.7% |
|
| Interacting |
| Product Used For Unknown Indication |
72.7% |
| Bronchopulmonary Aspergillosis |
13.6% |
| Peptic Ulcer |
13.6% |
|
| Drug Interaction |
50.0% |
| Pleural Effusion |
25.0% |
| Vascular Pseudoaneurysm |
25.0% |
|
